関連レポート

血液検査の世界市場：2031年予測

出版元：Transparency Market Research  出版元について

発行年：2024年2月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 185ページになります。

商品コード：TMR224

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

ピロリ菌非侵襲的検査の世界市場規模は2022年で5億4960万ドル、2031年に7億8820万ドル、市場の平均年成長率は4.2%にて増加する見込みです。

当レポートでは、ピロリ菌非侵襲的検査の市場予測-2031年、各種セグメント別市場分析(テストタイプ別、テスト方法別、国地域別、等)、パイプライン分析、主要製品/ブランド分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ピロリ菌非侵襲的検査の世界市場予測2023-2031年
・市場規模(US$)

■テストタイプ別、市場-2031年
・血清検査
・便抗原検査 (SAT)
・尿素呼気検査 (UBT)
※(市場規模US$)　

■テスト方法別、市場-2031年
・ラボラトリー検査
・ポイントオブケア検査(PoC)
※(市場規模US$)

■エンドユーザー別、市場-2031年
・病院
・クリニック
・診断ラボ
※(市場規模US$)

■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照


■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■ピロリ菌非侵襲的検査の主要企業プロフィール動向
DiaSorin S.p.A.
Meridian Bioscience, Inc.
Exalenz Bioscience Ltd.
Abbott
Thermo Fisher Scientific
Biomerica, Inc.
Certest Biotech S.L.
Sekisui Diagnostics
Coris Bioconcept
Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.


（全185頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Serology Test
6.3.2. Stool Antigen Test (SAT)
6.3.3. Urea Breath Test (UBT)
6.4. Market Attractiveness Analysis, by Test Type

7. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Method
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Method, 2017–2031
7.3.1. Laboratory-based Tests
7.3.2. Point-of-Care Tests
7.4. Market Attractiveness Analysis, by Test Method

8. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Diagnostic Laboratories
8.4. Market Attractiveness Analysis, by Test Method

9. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Serology Test
10.3.2. Stool Antigen Test (SAT)
10.3.3. Urea Breath Test (UBT)
10.4. Market Value Forecast, by Test Method, 2017–2031
10.4.1. Laboratory-based Tests
10.4.2. Point-of-Care Tests
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Diagnostic Laboratories
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Test Type
10.7.2. By Test Method
10.7.3. By End-user
10.7.4. By Country

11. Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Serology Test
11.3.2. Stool Antigen Test (SAT)
11.3.3. Urea Breath Test (UBT)
11.4. Market Value Forecast, by Test Method, 2017–2031
11.4.1. Laboratory-based Tests
11.4.2. Point-of-Care Tests
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratories
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Test Method
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Test Type, 2017–2031
12.3.1. Serology Test
12.3.2. Stool Antigen Test (SAT)
12.3.3. Urea Breath Test (UBT)
12.4. Market Value Forecast, by Test Method, 2017–2031
12.4.1. Laboratory-based Tests
12.4.2. Point-of-Care Tests
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratories
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Test Method
12.7.3. By End-user
12.7.4. By Country/Sub-region

13. Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Test Type, 2017–2031
13.3.1. Serology Test
13.3.2. Stool Antigen Test (SAT)
13.3.3. Urea Breath Test (UBT)
13.4. Market Value Forecast, by Test Method, 2017–2031
13.4.1. Laboratory-based Tests
13.4.2. Point-of-Care Tests
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratories
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Test Method
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Test Type, 2017–2031
14.3.1. Serology Test
14.3.2. Stool Antigen Test (SAT)
14.3.3. Urea Breath Test (UBT)
14.4. Market Value Forecast, by Test Method, 2017–2031
14.4.1. Laboratory-based Tests
14.4.2. Point-of-Care Tests
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratories
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Test Method
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. DiaSorin S.p.A.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Meridian Bioscience, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Exalenz Bioscience Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Thermo Fisher Scientific
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Biomerica, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Certest Biotech S.L.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Sekisui Diagnostics
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Coris Bioconcept
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
15.3.10.1. Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 07: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 08: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 12: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 15: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 16: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 20: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

Table 23: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

Table 24: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Type, 2022

Figure 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Type, 2022

Figure 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Method, 2022

Figure 05: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2022

Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by End-user, 2022

Figure 07: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End-user, 2022

Figure 08: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Region, 2022

Figure 09: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, 2023–2031

Figure 10: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 11: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 12: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 13: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 14: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 15: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2022–2031

Figure 16: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Region, 2022–2031

Figure 17: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Region, 2022–2031

Figure 18: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 19: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country, 2023–2031

Figure 20: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country, 2022–2031

Figure 21: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 22: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 23: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 24: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 25: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 26:North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 27: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 28: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 29: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 30: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 31: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 32: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 33: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 34: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 35: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 36: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 37: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 39: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 40: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 41: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 42: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 43: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 44: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 45: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 46: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 47: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 48: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 49: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 50: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 51: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 52: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 53: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 54: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 55: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 57: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

Figure 58: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

Figure 59: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

Figure 60: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 61: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

Figure 62: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031"

△ 一番上に戻る